Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy

International Journal of Urology ◽

10.1111/iju.12856 ◽

2015 ◽

Vol 22 (9) ◽

pp. 834-834

Author(s):

Robert J van Soest

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Editorial Comment ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Poor Clinical Outcome ◽

Lymphocyte Ratio ◽

Castration Resistant ◽

Docetaxel Chemotherapy

Download Full-text

High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy

International Journal of Urology ◽

10.1111/iju.12839 ◽

2015 ◽

Vol 22 (9) ◽

pp. 827-833 ◽

Author(s):

Akihisa Yao ◽

Takehiro Sejima ◽

Hideto Iwamoto ◽

Toshihiko Masago ◽

Shuichi Morizane ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Poor Clinical Outcome ◽

Lymphocyte Ratio ◽

Castration Resistant ◽

Docetaxel Chemotherapy

Download Full-text

High neutrophil to lymphocyte ratio (NLR) persistence during enzalutamide to predict poor clinical outcome in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e16059 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e16059-e16059 ◽

Author(s):

Ugo De Giorgi ◽

Simon J. Crabb ◽

Robert J. Jones ◽

Orazio Caffo ◽

Tony Elliott ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Poor Clinical Outcome ◽

Lymphocyte Ratio ◽

Castration Resistant

Download Full-text

S&T-06 HIGH ABSOLUTE MONOCYTE COUNT PREDICTS POOR CLINICAL OUTCOME IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH DOCETAXEL CHEMOTHERAPY

The Journal of Urology ◽

10.1016/j.juro.2016.02.2835 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Keisuke Shigeta ◽

Takeo Kosaka ◽

Toshiaki Shinojima ◽

Ryuichi Mizuno ◽

Eiji Kikuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Monocyte Count ◽

Castration Resistant Prostate Cancer ◽

Poor Clinical Outcome ◽

Castration Resistant ◽

Docetaxel Chemotherapy

Download Full-text

Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel risk stratification model in castration-resistant prostate cancer patients treated with docetaxel chemotherapy

Urological Science ◽

10.1016/j.urols.2015.06.005 ◽

2015 ◽

Vol 26 (2) ◽

pp. S27

Author(s):

Yoshihiro Nakagami ◽

Jun Nakashima ◽

Yoshio Ohno ◽

Makoto Ohori ◽

Masaaki Tachibana

Keyword(s):

Prostate Cancer ◽

Risk Stratification ◽

Cancer Patients ◽

Prognostic Value ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Lymphocyte Ratio ◽

Castration Resistant ◽

Risk Stratification Model ◽

Docetaxel Chemotherapy

Download Full-text

High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

Annals of Surgical Oncology ◽

10.1245/s10434-016-5354-5 ◽

2016 ◽

Vol 23 (12) ◽

pp. 4115-4122 ◽

Author(s):

Keisuke Shigeta ◽

Takeo Kosaka ◽

Shigehisa Kitano ◽

Yota Yasumizu ◽

Yasumasa Miyazaki ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Monocyte Count ◽

Castration Resistant Prostate Cancer ◽

Poor Clinical Outcome ◽

Castration Resistant ◽

Docetaxel Chemotherapy

Download Full-text

MP87-02 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND ESTABLISHMENT OF NOVEL RISK STRATIFICATION MODEL IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH DOCETAXEL CHEMOTHERAPY

The Journal of Urology ◽

10.1016/j.juro.2015.02.1947 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Yoshihiro Nakagami ◽

Jun Nakashima ◽

Yoshio Ohno ◽

Ohori Makoto ◽

Masaaki Tachibana

Keyword(s):

Prostate Cancer ◽

Risk Stratification ◽

Cancer Patients ◽

Prognostic Value ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Lymphocyte Ratio ◽

Castration Resistant ◽

Risk Stratification Model ◽

Docetaxel Chemotherapy

Download Full-text

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer

PLoS ONE ◽

10.1371/journal.pone.0158952 ◽

2016 ◽

Vol 11 (7) ◽

pp. e0158952 ◽

Author(s):

Vincenza Conteduca ◽

Simon J. Crabb ◽

Robert J. Jones ◽

Orazio Caffo ◽

Tony Elliott ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Outcome ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Lymphocyte Ratio ◽

Castration Resistant

Download Full-text

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

ESMO Open ◽

10.1016/j.esmoop.2021.100241 ◽

2021 ◽

Vol 6 (5) ◽

pp. 100241

Author(s):

R. de Wit ◽

C. Wülfing ◽

D. Castellano ◽

G. Kramer ◽

J.-C. Eymard ◽

...

Keyword(s):

Prostate Cancer ◽

Prognostic Biomarker ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Lymphocyte Ratio ◽

Castration Resistant ◽

Predictive And Prognostic Biomarker

Download Full-text

Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-020-0209-3 ◽

2020 ◽

Vol 23 (2) ◽

pp. 220-231 ◽

Author(s):

Yupeng Guan ◽

Haiyun Xiong ◽

Yupeng Feng ◽

Guolong Liao ◽

Tongyu Tong ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Meta Analysis ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Platelet To Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Castration Resistant

Download Full-text

2578 Neutrophil-to-lymphocyte ratio (NLR) in relation to outcome of castration-resistant prostate cancer (CRPC) patients treated with corticosteroids (CS)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31397-1 ◽

2015 ◽

Vol 51 ◽

pp. S504

Author(s):

N. Mehra ◽

D. Lorente ◽

A. Jayaram ◽

D. Bianchini ◽

Z. Zafeiriou ◽

...

Keyword(s):

Prostate Cancer ◽

Neutrophil To Lymphocyte Ratio ◽

Castration Resistant Prostate Cancer ◽

Lymphocyte Ratio ◽

Castration Resistant

Download Full-text